Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Pharmacopsychiatry|October 1, 1998
Combined treatment of schizophrenic psychoses with haloperidol and valproateM Dose, R Hellweg, A Yassouridis, et al.Psychoneuroendocrinology|January 1, 1986
Use of calcium antagonists in maniaM Dose, H M Emrich, C Cording-Tömmel, et al.Der Nervenarzt|July 1, 1994
[Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence]G Wiedemann, K Hahlweg, G Hank, et al.European Archives of Psychiatry and Clinical Neuroscience|June 16, 2001
Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophreniaG Wiedemann, K Hahlweg, U Müller, et al.Experimental Neurology|July 1, 1997
Time course of changes in lactate and free fatty acids after experimental brain injury and relationship to morphologic damageH S Dhillon, J M Dose, S W Scheff, et al.Journal of Hospice and Palliative Nursing : JHPN : the Official Journal of the Hospice and Palliative Nurses Association|August 1, 2018
Outcomes of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer Undergoing ChemotherapyAnn M Dose, Pamela J McCabe, Catherine A Krecke, et al.Journal of Neural Transmission. Supplementum|September 10, 2004
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's diseaseA Beister, P Kraus, W Kuhn, et al.Schizophrenia Bulletin|January 1, 1994
Deliverability of psychoeducational family managementG Wiedemann, K Hahlweg, G Hank, et al.Pharmacology, Biochemistry, and Behavior|September 23, 1997
Impact of d-amphetamine on temporal estimation in pigeons tested with a production procedureP J Kraemer, C K Randall, J M Dose, et al.Plant Physiology|July 1, 1997
The ferredoxin-binding site of ferredoxin: Nitrite oxidoreductase. Differential chemical modification of the free enzyme and its complex with ferredoxinM M Dose, M Hirasawa, S Kleis-SanFrancisco, et al.Pageof 8